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Detection of Class-Specific Antibodies of Pemphigus Vulgaris Using a 
Solid Phase Radioimmunoassay 
RICHARD L MURAHATA, PH.D. AND A. RAZZAQUE AHMED, M_D_ 
Division of Derm.alology, UCLA School of Medicine, Los Angeles, Califom ia, U. .A. 
A sensitive solid phase radioimmunoassay was devel-
oped to d e tect class-specific pemphigus antibodies. 
COLO-16, a cell line derived from a human squamous 
cell carcinoma of the skin, was used as the substrate, 
since this cell line has been shown by indirect immuno-
fluorescence to bind IgG antibodies in sera from patients 
with pemphigus vulgaris, but not from those with bul-
lous pemphigoid. IgG antibodies to COLO-16 were sig-
nificantly greater in sera from 17/24 patients (p < 0.05) 
with pemphigus vulgaris than in sera obtained from a 
control population consisting of normal volunteers and 
patients with other dermatologic diseases. The relative 
binding of the positive sera correlated well (p < 0.05, by 
Spearman's rank correlation test), with the endpoint 
determined by indirect immunofluorescence against 
monkey esophagus. This technique is 10-100 times more 
sensitive than immunofluorescence for the de tection of 
pemphigus antibodies and wi~l be useful in studying the 
cellular m echanisms controlling the synthesis of pem-
phigus antibody in vitro. 
Pemphigus vulgaris is a disease characterized by flaccid bul-
lae on the skin and/or mucous membranes. Present evidence 
suggests that the pathogenesis of pemphigus vulgal'is is related 
to the production of autoantibodies directed against antigens 
present on the surface of squamous epithelial cells a nd the 
intercellulru' substa nce (ICS) of the squamous epithelium 
[1-6]. Antibodies of the IgG class have been demonstrated by 
direct immunofluorescence at the site of pathology in perile-
sional skin biopsies obtained from patients, a nd IgG an t ibodies 
with anti-ICS reactivity have been detected in the serum of 
most patients [1,2). R ecent evidence from in vitro studies has 
supported the central role of these autoantibodies in the patho-
genesis of the disease. Acantholysis of skin explants has been 
demonstrated by in vitro incubation of the expla n ts in the 
presence of pemphigus serum [3). Binding of IgG from pem-
phigus serum to epi thelial cells in vitro in tel'ferred with epider-
mal cell attachment to cultlll'e dishes [4] a nd resul ted in the 
activation of cell sUl'face proteolytic enzymes which were ca-
pable of detaching epidermal cells from cul t lll'e plates [5] a nd 
disrupting the ICS of skin explants [6). 
Pemphigus antigens have been demonstrated in normal hu -
ma n s kin and in the squamous epitheliulll of several other 
ma mmalia n species [7-10). Antigenic material has been de-
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tected in extracts from skin , esophagus, and saliva by the 
blocking of indi.rect immunofluorescence of a known positive 
serum [7-10]. In th ese investigations, t he amount of material 
obtained has been limited a nd primarily used for the biochem-
ical cha racterization of th e antigen . Pemphigus sera have also 
been shown to react with sections of human squamous cell 
tumors [11]. We have recently shown that COLO-16, a tumor 
cell line derived from a squamous cell carcinoma of th e skin 
reacted with sera from pemphigus patients, but not with sera 
from pemphigoid patients [12]. We report here the development 
of a sensit ive solid phase radioimmunoassay for pemphigus 
a n t ibodies using COLO-16 as the substrate a nd radiolabeled 
goat antihuma n IgG as the indicator. 
MATERIALS AND METHODS 
Sera. 
Sera were obtained from 21 patients with pemphigus vulgaris during 
the acute phase of the illness. The diagnosis was made by the clinical 
presentation and was confirmed by positive direct immunofluorescence 
examination of pel'ilesional skin which demonstrated a deposition of 
IgG in the ICS. Sera were tested for anti-ICS antibodies of the IgG 
class by standru'd immunoflu orescence techniques using monkey eSfJph-
agus as the substrate. All pemphigus were positive with endpoint titers 
ranging from 10-640. Sera obtained fTom 17 normal donors and patients 
with other dermatologic diseases were used as contro\. The sera used 
in this study a.re described in Table I. 
Cell Lines 
The tumor cell line COLO-16 was obtained from Dr. G. E. Moore, 
Denver General Hospital, Denver, Colorado. It has been characterized 
as a squamous cell carcinoma [12] and has been maintained ill vitro for 
several years. The cell line was passaged weekly in RPMI 1640 supple-
mented with 5% heat inactivated newboJ"l1 calf serum, L-glu tamine 
(GIBCO, Grand I land, New York), and gentamicin (M I A Bioproducts, 
Walkersville, Maryland). All experimen ts reported here used cells from 
passages 40-50. 
Rac/ioiodinatioll of Antibodies 
T he IgG fraction of goat anti-human IgG (Cappel Laboratories, 
Cochranville, Pennsylvania) was iodinated by the chloramine T method 
[14], and the labeled antibody was separated from unreacted iodine by 
gel chromatography. 
Radioilll.lnultoassay 
Tumor cells (1.5-3.0 x 10") in 0. 2 ml medium were added to half of 
the wells of Cooke-V-bottom microtiter plates. The remaining wells 
received 0.2 ml medium alone. T he plates were incubated for 3 days at 
37°C in a humidified atmosphere of 5% CO" in air. T he wells were 
emptied and washed 3 times with phosphate buffered saline (PBS, pH 
7.0) containing 1% ovalbumin (OA). Replicate 75 It! samples of several 
dilutions of sera (usually 1:320-1:5120) were added to both control wells 
and wells containing COLO-16 cells. The plate was incubated overnight 
at room temperature in a humidified chamber. The plate was emptied, 
washed 3 times with PBS + 1% OA, and 5 x 10" cpm '""I- labeled was 
added in a total volume of 50 III (specific activi ty adjusted t.o 1 x 10" 
cpm/ flg antibody with unlabeled antibody) . After 5 hI' incubation at 
room temperature, the plate was washed 3 limes with PBS + 1% OA 
and 10 times with running tap water. T he plate was dried and the wells 
counted individually in an automat.ic gamma counter. Results ru'e 
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TABLE 1. Sera used in study 
Palienl Dale of sample Clinical di agnosis" 1IF Find ings" 
LF 8/15/79 PV rcs 320 
JMcC 7/9/80 PV rcs 80 
HB 11/1/50 PV rcs 40 
ASc 3/19/79 PV ICS 80 
IRd 10/22/80 PV ICS 40 
MB 3/19/79 PV rcs 80 
ZA 9/3/80 PV ICS 320 
MP 10/7/80 PV lCS 640 
JCh 9/13/80 PV ICS 640 
JQ 10/10/80 PV ICS 40 
AM 10/24/80 PV rcs 80 
JR 3/22/79 PV rcs 160 
GT 3/21/ 79 PV rcs 160 
MS 3/19/79 PV rcs 40 
WM 8/21/79 PV ICS 320 
ER 10/10/79 PV lCS 160 
SW 7/8/80 PV rcs 320 
CC 7/9/80 PV ICS 80 
rM 10/17/80 PV ICS 640 
JH 7/9/80 PV rcs 40 
IRf 11/26/80 PV rcs 80 
DPr 11/26/80 PV ICS 80 
GO 7/10/80 PV ICS 20 
CF 7/23/80 PV rcs 10 
HS 11/7/80 
DPf 6/2/75 
ED 10/22/80 
CM 11/6/80 
RM 11/20/80 
ASh 10/9/79 )3p BW 10/20/80 BMZ 80 
ASy 10/22/80 BP BMZ 160 
GW 8/22/79 BP BMZ 10 
MJ 3/15/79 BP BMZ 1280 
EL 10/23/79 BP BMZ 640 
PG 11/5/79 BP BMZ 640 
MJ 3/.15/79 SLE ANA 80 
WS 3/9/79 DLE 
JCl 3/7/79 DH 
LP 8/7/79 DH 
HI' 1/12/70 DH 
KMcK 2/7/79 DH 
"PV-Pemphigus vulgaris; BP-buUous pemphigoid; SLE-sys-
temic lupus erythematosus; DLE-discoid lupus erythematosus; DH-
dermatitis herpetiformis. 
/, Titers are expressed as the reciprocal of the highest di lution of 
serum giving a clear positive staining. ICS- Intercellular substance; 
BMZ-basement membrane zone; ANA-anti-nuclear antibodies. 
/ ' 
expressed as net cpm bound (i.e., cpm bound in wells containing COLO-
16 minus cpm in wells containing culture medium alone) or as relative 
cpm bound which was calculated according to the following formu la: 
percent relative cpm bound = 
net cpm bound with sample serum 
X 100 
net cpm bound with reference serum 
The endpoint was defined as the reciprocal of the highest dilution of' 
serum resulting in a per cent relative binding greater than 2 standard 
deviations above the mean of control sera. 
RESULTS 
Serum from patient LF was chosen for preliminaTY studies 
liince previous investigations using indirect immunofluores-
cence showed that this serum has a high reactivity against the 
tumor cell line [12]. The binding of IgG from the serum of 
patient LF was dil'ectly related to the number of COLO-16 cells 
plated in the wells and inversely related to the dilution of the 
serum (Fig 1). Note that the wells seeded with the lower number 
of cells show the expected saturation of binding at lower serum 
dilutions. Saturation of the wells receiving the higher numbers 
of cells was observed with serum dilutions of 1:20-1:80. F urther 
experiments were done using a seeding dose of 1.5-3.0 x 10f, 
Vo l. 79, No . 2 
cells per well since this resulted in a dose-dependent binding of 
serum LF in the dilution range of 1:320-1:5120. 
The specificity of the binding was tested by comparing the 
binding of sera obtained from pemphigus patients to that ob-
served with sera obtained from normal donors 01' from patients 
with other skin disorders in which immunoglobulin deposition 
in the skin has been reported (bullous pemph igoid, dermatitis 
herpetiformis, systemic lupus erythematosus, and discoid lup us 
erythematosus). T he results of two representative experiments 
are shown in Fig 2. All of the pemphigus sera tested in this 
experiment bound to the tumor cells in a dose-dependent 
fashion, while those obtained from control patients showed low 
levels of binding at all dilutions tested. T he binding activity of 
serum LF was reduced 22%, 29%, and 38% respectively by 1, 2, 
and 3 serial absorbtions on monolayers of COLO-16 cells. Con-
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FIG 1. Checkerboard t itration of serum LF and the number of 
COLO-16 cells ini tially plated into microtiter wells, indicated by the 
numbel's to t he right of each line. IgG bound to the COLO-J6 cells was 
detected by the addition of 125-I-labelled goat anti-human IgG. 
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FIG 2. T itration of the IgG anti-COLO 16 activity or various era. 
Sera from pemphigus vulgaris patients LF, JR, JM, CT, and MS 
showed significant binding comparable to their immunotluorescent 
endpoints.of 320, 160, 80, 160, and 40 respectively. WS, MJ , and BZ 
had othel' dermatologic disease; HS was a normal donor. 
\ 
Aug. 1982 RIA FOR THE DETECTION OF PEMPHIGUS VULGARIS ANTIBODIES 67 
trot absorbtions on calf serum coated plates removed 2-11% of 
the activity. 
In order to compare results from different experiments, serum 
from LF was used as an internal reference, and the binding of 
other sera was expressed as per cent of binding by the reference 
serum. Although there was significant day to day variation in 
the absolute number of counts bound by a given serum, there 
was little variation in the when the results were expressed as 
percent of reference (Table II) which is an indication of the 
internal consistency of this test. The pooled results of 9 exper-
iments are shown in Fig 3. The mean percent relative binding 
of the 14 nonpemphigus control sera was 10% (range 1-22%) at 
a dilution of 1:320 and 6% (range 1-12%) at a dilution of 1:1280. 
A patient's serum was considered to be positive if it exhibited 
a relative binding greater than 2 standard deviations above the 
control mean (24% at a dilution of 1:320). Using this criterion, 
the pemphigus patients could be divided into two groups: the 
majority (17/24) which was positive for binding at a dilution of 
1:320 and a subpopulation (7/24) whose binding fell within the 
normal range. It is important to note that all of the sera that 
fell within the normal range of binding by the RIA had immu-
nofluorescent titers of 40 or greater. The significance of the 2 
populations is unknown at this time and will be the subject of 
futw-e studies. The relative binding of positive sera correlated 
strongly with the endpoint determined by routine indirect 
immunofluorescence (p < 0.05 by Spearman's rank correlation 
test) . On the basis of endpoint titration this RIA is between 10-
TABLE II. R eproducibility of relative binding 
Serum 
RS 
DPr 
IRf 
VB 
Relative binding 
(Mean ± SEM) 
71 ± 4 
55 ± 5 
49 ± 6 
5±2 
Sera were tested at a dilu tion of 1:320 and the percent relative 
binding calculated as described in the Materials and Methods. Data 
shown is the result of triplicate determinations of experiments run on 
4 different days. Variability in the net cpm bound by the reference 
seru m LF was 22,300 ± 7,000. 
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FIC 3. RIA for IgG antibodies to COLO-16 in sera from patients 
with pemph igus vulgaris and controls consisting of normal donors and 
patients with other dermatologic diseases. ALI sera were tested at a 
dilution of 1:320, and the results are norma lized to the binding exhibi ted 
by serum LF. 
TABLE III. Comparison of sensitivity of RIA and IIP 
llF Titer" 
RIA Endpoint" 
320 1280 5120 
10 X (128) <-
20 X (64) 
40 X (8) XX (32) 
80 XXX (64) 
160 XX (32) 
320 XXXX (16) 
640 XXX (8) 
"The reciprocal of the highest dilution giving clearly positive ICS 
staining on monkey esophagus. 
" T he reciprocal of the highest dilution resulting in percent relative 
binding greater than 2 SD above the mean of control sera. 
C The ratio of RIA endpoint to IIF titer. 
100 times more sensitive than the indirect immunofluorescence 
assay for the detection of pemphigus antibodies (Table III). 
DISCUSSION 
Disorders of immune regulation have been postulated to be 
the primary defect in many autoimmune diseases [15]. The 
ability to study the immune response in vitro in such diseases 
has been hampered by the lack of a source of antigen both for 
the stimulation of antibody production and for the quantitation 
of specific antibody production. We consider pemphigus vul-
garis a highly appropriate model for organ specific autoimmune 
diseases because the evidence for the autoimmune pathogenesis 
is strong and there are no gross immunological abnormalities 
associated with the disease. The highly sensitive assay reported 
here will allow the investigation of the mechanisms that control 
the synthesis of pemphigus autoantibody in vitro. 
The observation that sera from a subpopulation of patients 
with t his disease do not react with COLO-16 cells has important 
implications. It is fw-ther evidence that the pemphigus antigen, 
and therefore the pemphigus antibody, is not a unique entity, 
but rather a family of specificities related by anatomical local-
ization, as was suggested earlier by Shu and Beutner [7]. It 
remains to be determined which of the many specificities are 
important in the pathology of the disease. 
While the inability of the COLO-16 RIA to detect antibodies 
in the sera of all pemphigus patients will limit the clinical utility 
of the test, it will permit the study of subpopulations of pem-
phigus patients. We are presently studying the binding of 
pemphigus sera to SCaBER, another squamous cell tumor line 
which is recognized by some pemphigus sera [12]. It is possible 
that the antigenic determinants are not identical and will allow 
further classification of pemphigus antigens and patients. 
Preliminary studies indicate that this RIA is capable of 
detecting pemphigus antibodies synthesized in vitro. Extraction 
and purification of antigenic material is cmrently in progress 
and will facilitate studies on cellular mechanisms of immune 
regulation in this disease. 
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Richner-Hanhart's Syndrome: Ultrastructural Abnormalities of 
Epidermal Keratinization Indicating a Causal Relationship to High 
Intracellular Tyrosine Levels 
AXEL BOHNERT, M.D., AND INGRUN ANTON-LAMPRECHT, SC.U. 
Tnstitut fuel' Ultrastruhturforschung del' Haut, Hautklinik del' Ruprecht-Karls- Uniuer;;itaet, Heidelberg, Gennany 
Richner-Hanhart's syndrome (corneal dystrophies, 
palmoplantar keratoses, and mental retardation) is 
caused by high levels ofL-tryosine in the blood, probably 
due to a defect of soluble tryosine aminotransferase. 
Biopsies of skin lesions of 3 cases revealed peculiar ul-
trastructural changes that were not found in controls 
and have not been recorded before. Thickening of the 
granular layer and increased synthesis of tonofibrils and 
keratohyalin occurred in all cases. In the ridged palmar 
or plantar skin large numbers of microtubules and un-
usually tight packing of tonofibrillar masses were regu-
larly demonstrable, the latter containing tubular chan-
nels or inclusions of microtubules. It is assumed that 
increased cohesion and tight packing of tonofilaments 
could prevent / normal spreading of keratohyalin and 
result in its globular appearance. No crystal formation 
was observed in epidermal keratinocytes nor was there 
lysosomal damage. 
A biochemical model to correlate these ultrastructural 
findings to known biochemical and cUuical features is 
proposed. It is suggested that excessive amounts of in-
tracellular tryosine enhance cross-links between aggre-
gated tonofilaments and modulate the number and sta-
bility of microtubules. 
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Abbreviations: 
KH: Keratohyalin 
MT: Microtubules 
RHS: Richner-Hanhart's Syndrome 
TF: Tonofibrils 
Richner-Hanhart's syndrome (RHS), now also called oculo-
cutaneous tyrosinosis, is an autosomal recessively inherited 
disease with painful circumscript palmar and plantar hyperker-
atotic lesions, herpetiform corneal dystrophies, and oligo-
phrenia [1,2]. These symptoms are combined with abnormally 
high levels of L-tyrosine in the blood [3]. Clinical manifestation 
of the disease has been shown to be suppressible by a low-
tyrosine diet [3-8]. Analogous symptoms, i.e., inflammatory 
hyperkeratotic lesions on the toes, keratitis, conjunctivitis, al-
opecia, and cheilitis, have been provoked in rats by a high-
tyrosine diet [9]. 
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FIG 1. ' Pedigree of case 1, showing consanguinly of the parents. 
